Pfizer Canada and partners announce quality improvement grant recipients for Canada’s most prevalent cancers
This World Cancer Day, Pfizer Canada ULC, together with Rethink Breast Cancer, Colorectal Cancer Canada, Lung Health Foundation, Lung Cancer Canada, and the Quebec Lung Association, is pleased to announce the 2024 recipients of a series of grants to help advance oncology care and innovation in Canada. The competitive grants are awarded for proposals that aim to improve the quality of cancer care for Canadians living with metastatic cancer such as non-small cell lung cancer, colorectal cancer, prostate cancer or breast cancer.